Screener
Corvus Pharmaceuticals CRVS Book value per share
Book value per share at other companies
Other financials
Where this comes from
Calculated from Corvus Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The source filing: Corvus Pharmaceuticals’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 4:05 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-057100
FAQ
- What is Corvus Pharmaceuticals's book value per share?
- Corvus Pharmaceuticals (CRVS) reported book value per share of $2.67 in Q1 2026.
- How has Corvus Pharmaceuticals's book value per share changed year-over-year?
- Corvus Pharmaceuticals's book value per share increased by 307.5% year-over-year, from $0.66 to $2.67.
- What is the long-term trend for Corvus Pharmaceuticals's book value per share?
- Over 5 years (2020 to 2025), Corvus Pharmaceuticals's book value per share has grown at a -20.7% compound annual growth rate (CAGR), from $2.45 to $0.77.
- What does book value per share mean?
- Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.
Ask your AI about Corvus Pharmaceuticals's book value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude